SERUM HBSAG LEVELS DURING PEGINTERFERON ALFA-2A TREATMENT IN HBEAG-POSITIVE CHRONIC HEPATITIS B: A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL

被引：0
|
作者：
Kim, Bo Hyun [1 ,2 ]
Kim, Won [3 ]
Song, Fun Young [4 ]
Park, Myoung Hee [4 ]
Yoon, Jung-Hwan [5 ,6 ]
Lee, Youn Jae [7 ]
Park, Sung Jae [7 ]
Jung, Eun Uk [7 ]
Kim, Donghee [8 ]
Kim, Yoon Jun [5 ,6 ]
Lee, Hyo-Suk [5 ,6 ]
机构：
[1] Bundang Jesaeng Gen Hosp, Dept Internal Med, Songnam, South Korea
[2] Bundang Jesaeng Gen Hosp, Hepatol Ctr, Songnam, South Korea
[3] Seoul Metropolitan Govt Seoul Natl Univ Boramae M, Dept Internal Med, Seoul, South Korea
[4] Seoul Natl Univ, Coll Med, Dept Lab Med, Seoul, South Korea
[5] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea
[6] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea
[7] Inje Univ, Paik Hosp, Dept Internal Med, Pusan, South Korea
[8] Seoul Natl Univ Hosp, Gangnam Healthcare Ctr, Inst Healthcare Res, Seoul 110744, South Korea
来源：
HEPATOLOGY | 2010年 / 52卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
390
引用
收藏
页码：514A / 514A
页数：1
相关论文
共 50 条
  • [1] ON-TREATMENT MONITORING OF HBsAg LEVELS TO PREDICT RESPONSE TO PEGINTERFERON ALFA-2A IN PATIENTS WITH HBeAg-POSITIVE CHRONIC HEPATITIS B
    Lau, G. K. K.
    Marcellin, P.
    Brunetto, M.
    Piratvisuth, T.
    Kapprell, H. -P
    Messinger, D.
    Popescu, M.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S333 - S333
  • [2] Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B
    Lau, GKK
    Piratvisuth, T
    Luo, KX
    Marcellin, P
    Thongsawat, S
    Cooksley, G
    Gane, E
    Fried, MW
    Chow, WC
    Paik, SW
    Chang, WY
    Berg, T
    Flisiak, R
    McCloud, P
    Pluck, N
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (26): : 2682 - 2695
  • [3] Association between Genotype and the HBsAg Levels at HBeAg Loss in HBeAg-positive Chronic Hepatitis B Patients Treated with Entecavir or Peginterferon Alfa-2a
    Peng, Cheng-Yuan
    Lai, Hsueh-Chou
    Su, Wen-Pang
    Lin, Chia-Hsin
    Chuang, Po-Heng
    Chen, Sheng-Hung
    HEPATOLOGY, 2014, 60 : 1121A - 1121A
  • [4] Peginterferon alfa-2b in the treatment of Chinese patients with HBeAg-positive chronic hepatitis B: A randomized trial
    Cheng, Jun
    Wang, Yuming
    Hou, Jinlin
    Luo, Duande
    Xie, Qing
    Ning, Qin
    Ren, Hong
    Ding, Huiguo
    Sheng, Jifang
    Wei, Lai
    Chen, Shijun
    Fan, Xiaoling
    Huang, Wenxiang
    Pan, Chen
    Gao, Zhiliang
    Zhang, Jiming
    Zhou, Boping
    Chen, Guofeng
    Wan, Mobin
    Tang, Hong
    Wang, Guiqiang
    Yang, Yuxiu
    Mohamed, Rosmawati
    Guan, Richard
    Lee, Tzong-Hsi
    Chang, Wen-Hsiung
    Huang Zhenfei
    Ye, Zhang
    Xu, Daozhen
    JOURNAL OF CLINICAL VIROLOGY, 2014, 61 (04) : 509 - 516
  • [5] HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B
    Fried, Michael W.
    Piratvisuth, Teerha
    Lau, George K. K.
    Marcellin, Patrick
    Chow, Wan-Cheng
    Cooksley, Graham
    Luo, Kang-Xian
    Paik, Seung Woon
    Liaw, Yun-Fan
    Button, Peter
    Popescu, Matei
    HEPATOLOGY, 2008, 47 (02) : 428 - 434
  • [6] Serum HBV RNA as a Predictor of Peginterferon Alfa-2a Response in Patients With HBeAg-Positive Chronic Hepatitis B
    van Boemmel, Florian
    van Boemmel, Alena
    Krauel, Alexander
    Wat, Cynthia
    Pavlovic, Vedran
    Yang, Lei
    Deichsel, Danilo
    Berg, Thomas
    Boehm, Stephan
    JOURNAL OF INFECTIOUS DISEASES, 2018, 218 (07): : 1066 - 1074
  • [7] Efficacy and safety of peginterferon alfa-2a in Chinese patients with HBeAg-positive chronic hepatitis B
    Xu, D. -Z.
    Xie, Y.
    Wei, L.
    Chen, X. Y.
    Wan, M. -B.
    Wang, Y. -M.
    Wang, L.
    Wei, J.
    Gan, J. -H.
    Tian, D. -Y.
    Zhang, S. -L.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S266 - S266
  • [8] Serum HBsAg Levels During Peginterferon α-2a Treatment With or Without Thymosin α-1 in HBeAg-Positive Chronic Hepatitis B Patients
    Song, Eun Young
    Shin, Yunsu
    Roh, Eun Youn
    Sue, Shin
    Park, Myoung Hee
    Kim, Bo Hyun
    Kim, Won
    Yoon, Jung-Hwan
    Lee, Youn-Jae
    Park, Sung Jae
    Jung, Eun Uk
    Lee, Jeong-Hoon
    Myung, Sun Jung
    Kim, Yoon-Jun
    Lee, Hyo-Suk
    JOURNAL OF MEDICAL VIROLOGY, 2011, 83 (01) : 88 - 94
  • [9] Peginterferon alfa-2b alone or in combination with lamivudine for chronic HBeAg-positive hepatitis B: a randomized controlled trial.
    Janssen, HLA
    van Zonneveld, M
    Senturk, H
    Zeuzem, S
    Akarca, U
    Cakaloglu, Y
    Simon, K
    Kit, TSM
    Gerken, G
    de Man, RA
    Niesters, HGM
    Schalm, SW
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2005, 17 (01) : A11 - A11
  • [10] PREDICTORS OF DEVELOPMENT OF HBEAG-NEGATIVE CHRONIC HEPATITIS B FOLLOWING PEGINTERFERON ALFA-2A THERAPY IN HBEAG-POSITIVE CHRONIC HEPATITIS B
    Peng, Cheng-Yuan
    Shih, Chao-Jen
    Lo, Pei-Shuan
    Huang, Chia-Lin
    Lai, Hsueh-Chou
    Su, Wen-Pang
    Chuang, Po-Heng
    Kao, Jung-Ta
    HEPATOLOGY, 2011, 54 : 1027A - 1028A
12345